EMN Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
2.4B
-5.1%
2.5B
+15.4%
2.2B
+10.3%
2.0B
-10.4%
2.2B
Cost of Revenue
1.9B
-5.1%
2.0B
+11.9%
1.7B
+6.8%
1.6B
-7.6%
1.8B
Gross Profit
532.0M
-5.0%
560.0M
+29.9%
431.0M
+27.5%
338.0M
-21.9%
433.0M
Operating Expenses
234.0M
-6.8%
251.0M
+9.1%
230.0M
-8.0%
250.0M
+2.9%
243.0M
R&D
63.0M
-3.1%
65.0M
+8.3%
60.0M
+3.4%
58.0M
-7.9%
63.0M
SG&A
171.0M
-7.6%
185.0M
+3.9%
178.0M
+11.9%
159.0M
-0.6%
160.0M
Operating Income
298.0M
-3.6%
309.0M
+53.7%
201.0M
+128.4%
88.0M
-53.7%
190.0M
EBITDA
432.0M
-2.3%
442.0M
+29.6%
341.0M
+24.9%
273.0M
-19.5%
339.0M
Net Income
253.0M
+37.5%
184.0M
+72.0%
107.0M
+1.9%
105.0M
+52.2%
69.0M
EPS (Basic)
$2.21
+38.1%
$1.60
+72.0%
$0.93
+1.1%
$0.92
+53.3%
$0.60
EPS (Diluted)
$2.19
+37.7%
$1.59
+71.0%
$0.93
+1.1%
$0.92
+53.3%
$0.60
Shares (Diluted)
115.3M
+0.0%
115.3M
+0.3%
115.0M
+0.6%
114.3M
-1.0%
115.4M
Eastman Chemical (EMN) — Financials